Anlotinib and Benmelstobart in DTC
NCT07193186
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Thyroid Cancer
Interventions
DRUG:
Anlotinib and Benmelstobart
Sponsor
Fudan University